Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Scheithauer

Showing results (771-780 of 856) with videos related to

Pageof 86
Sort By:
Journal of Thrombosis and Haemostasis : JTH|April 24, 2012
Microparticle-associated tissue factor activity, venous thromboembolism and mortality in pancreatic, gastric, colorectal and brain cancer patientsJ Thaler, C Ay, N Mackman, et al.
Acta Neuropathologica|November 30, 2010
PI3K/AKT pathway alterations are associated with clinically aggressive and histologically anaplastic subsets of pilocytic astrocytomaErika F Rodriguez, Bernd W Scheithauer, Caterina Giannini, et al.
Journal of Neuro-Oncology|January 19, 1999
The results of radiotherapy for brainstem tumorsS E Schild, S L Stafford, P D Brown, et al.
Endocrine|April 11, 2008
Effects of TGFbeta1 on gene expression in the HP75 human pituitary tumor cell line identified by gene expression profilingKatharina H Ruebel, Alexey A Leontovich, Yoshinori Tanizaki, et al.
International Journal of Radiation Oncology, Biology, Physics|October 1, 1996
Nongerminomatous germ cell tumors of the brainS E Schild, M G Haddock, B W Scheithauer, et al.
Journal of Neurosurgery|July 1, 1993
Results of surgical treatment for growth hormone-secreting pituitary adenomasD H Davis, E R Laws, D M Ilstrup, et al.
Journal of Neuro-Oncology|December 1, 1996
Phase II study of 5-fluorouracil and leucovorin in recurrent primary brain tumorT L Cascino, M H Veeder, J C Buckner, et al.
Investigational New Drugs|September 1, 2005
Phase I/II trial of pyrazoloacridine and carboplatin in patients with recurrent glioma: a North Central Cancer Treatment Group trialEvanthia Galanis, Jan C Buckner, Matthew J Maurer, et al.
Investigational New Drugs|August 25, 2000
A North Central Cancer Treatment Group phase II trial of topotecan in relapsed gliomasP A Burch, A M Bernath, T L Cascino, et al.
International Journal of Radiation Oncology, Biology, Physics|December 24, 2005
Spinal cord gliomas: A multi-institutional retrospective analysisMay Abdel-Wahab, Blessing Etuk, James Palermo, et al.
Pageof 86

Showing results (771-780 of 856) with videos related to

Sort By:
Pageof 86
Journal of Thrombosis and Haemostasis : JTH|April 24, 2012
Microparticle-associated tissue factor activity, venous thromboembolism and mortality in pancreatic, gastric, colorectal and brain cancer patientsJ Thaler, C Ay, N Mackman, et al.
Acta Neuropathologica|November 30, 2010
PI3K/AKT pathway alterations are associated with clinically aggressive and histologically anaplastic subsets of pilocytic astrocytomaErika F Rodriguez, Bernd W Scheithauer, Caterina Giannini, et al.
Journal of Neuro-Oncology|January 19, 1999
The results of radiotherapy for brainstem tumorsS E Schild, S L Stafford, P D Brown, et al.
Endocrine|April 11, 2008
Effects of TGFbeta1 on gene expression in the HP75 human pituitary tumor cell line identified by gene expression profilingKatharina H Ruebel, Alexey A Leontovich, Yoshinori Tanizaki, et al.
International Journal of Radiation Oncology, Biology, Physics|October 1, 1996
Nongerminomatous germ cell tumors of the brainS E Schild, M G Haddock, B W Scheithauer, et al.
Journal of Neurosurgery|July 1, 1993
Results of surgical treatment for growth hormone-secreting pituitary adenomasD H Davis, E R Laws, D M Ilstrup, et al.
Journal of Neuro-Oncology|December 1, 1996
Phase II study of 5-fluorouracil and leucovorin in recurrent primary brain tumorT L Cascino, M H Veeder, J C Buckner, et al.
Investigational New Drugs|September 1, 2005
Phase I/II trial of pyrazoloacridine and carboplatin in patients with recurrent glioma: a North Central Cancer Treatment Group trialEvanthia Galanis, Jan C Buckner, Matthew J Maurer, et al.
Investigational New Drugs|August 25, 2000
A North Central Cancer Treatment Group phase II trial of topotecan in relapsed gliomasP A Burch, A M Bernath, T L Cascino, et al.
International Journal of Radiation Oncology, Biology, Physics|December 24, 2005
Spinal cord gliomas: A multi-institutional retrospective analysisMay Abdel-Wahab, Blessing Etuk, James Palermo, et al.
Pageof 86